High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape - Nature.com

Abstract

The number and variability of the neutralizing epitopes targeted by polyclonal antibodies in SARS-CoV-2 convalescent and vaccinated individuals are key determinants of neutralization breadth and the genetic barrier to viral escape^1–4. Using HIV-1 pseudotypes and plasma-selection experiments with vesicular stomatitis virus/SARS-CoV-2 chimeras⁵, we show that multiple neutralizing epitopes, within and outside the receptor binding domain (RBD), are variably targeted by human polyclonal antibodies. Antibody targets coincide with spike sequences that are enriched for diversity in natural SARS-CoV-2 populations. By combining plasma-selected spike substitutions, we generated synthetic ‘polymutant’ spike protein pseudotypes that resisted polyclonal antibody neutralization to a similar degree as circulating variants of concern (VOC). By aggregating VOC-associated and antibody-selected spike substitutions into a single polymutant spike protein, we show that 20 naturally occurring mutations in SARS-CoV-2 spike are sufficient to generate pseudotypes with near-complete resistance to the polyclonal neutralizing antibodies generated by convalescents or mRNA vaccine recipients. Strikingly, however, plasma from individuals who had been infected and subsequently received mRNA vaccination, neutralized pseudotypes bearing this highly resistant SARS-CoV-2 polymutant spike, or diverse sarbecovirus spike proteins. Thus, optimally elicited human polyclonal antibodies against SARS-CoV-2 should be resilient to substantial future SARS-CoV-2 variation and may confer protection against potential future sarbecovirus pandemics.

Download PDF

Author information

Author notes

1. These authors contributed equally: Fabian Schmidt, Yiska Weisblum

Affiliations

1. Laboratory of Retrovirology, The Rockefeller University, New York, NY, USA

   Fabian Schmidt, Yiska Weisblum, Daniel Poston, Justin Da Silva, Fengwen Zhang, Eva Bednarski, Theodora Hatziioannou & Paul D. Bieniasz

2. Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA

   Alice Cho, Dennis J. Schaefer-Babajew, Christian Gaebler, Marina Caskey & Michel C. Nussenzweig

3. Howard Hughes Medical Institute, The Rockefeller University, New York, NY, USA

   Magdalena Rutkowska, Michel C. Nussenzweig & Paul D. Bieniasz

Authors

1. Fabian Schmidt
   View author publications

   You can also search for this author in PubMed Google Scholar

2. Yiska Weisblum
   View author publications

   You can also search for this author in PubMed Google Scholar

3. Magdalena Rutkowska
   View author publications

   You can also search for this author in PubMed Google Scholar

4. Daniel Poston
   View author publications

   You can also search for this author in PubMed Google Scholar

5. Justin Da Silva
   View author publications

   You can also search for this author in PubMed Google Scholar

6. Fengwen Zhang
   View author publications

   You can also search for this author in PubMed Google Scholar

7. Eva Bednarski
   View author publications

   You can also search for this author in PubMed Google Scholar

8. Alice Cho
   View author publications

   You can also search for this author in PubMed Google Scholar

9. Dennis J. Schaefer-Babajew
   View author publications

   You can also search for this author in PubMed Google Scholar

10. Christian Gaebler
    View author publications

    You can also search for this author in PubMed Google Scholar

11. Marina Caskey
    View author publications

    You can also search for this author in PubMed Google Scholar

12. Michel C. Nussenzweig
    View author publications

    You can also search for this author in PubMed Google Scholar

13. Theodora Hatziioannou
    View author publications

    You can also search for this author in PubMed Google Scholar

14. Paul D. Bieniasz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Theodora Hatziioannou or Paul D. Bieniasz.

Supplementary information

Supplementary Table 1

TSubstitutions enriched in rVSV/SARS-CoV-2 following selection in neutralizing plasma. Tabulated SARS-CoV-2 spike substitutions and their frequencies in rVSV/SARS-CoV-2 following passage in each of the RU27 plasma samples.

Reporting Summary

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Schmidt, F., Weisblum, Y., Rutkowska, M. et al. High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape. Nature (2021). https://ift.tt/3hPZUKh

Download citation

• Received: 01 July 2021

• Accepted: 07 September 2021

• Published: 20 September 2021

• DOI: https://doi.org/10.1038/s41586-021-04005-0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Adblock test (Why?)

Article From & Read More ( High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape - Nature.com )
https://ift.tt/3EAwBFa
Health

Bagikan Berita Ini